Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®
Abstract Aims Centrifugal continuous flow pumps are currently the state of the art in left ventricular assist device therapy. This study was conducted to compare the results after implantation of the HVAD® and the HeartMate 3®. Methods and results We retrospectively analysed preoperative and post‐op...
Saved in:
| Main Authors: | Rene Schramm, Armin Zittermann, Michiel Morshuis, Michael Schoenbrodt, Ellen vonRoessing, Vera vonDossow, Andreas Koster, Henrik Fox, Kavous Hakim‐Meibodi, Jan F. Gummert |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-06-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.12649 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Flow dynamics during the HeartWare HVAD to HeartMate 3 exchange: A computational study assessing differential graft lengths and surgical techniques
by: Jonathan Grinstein, MD, et al.
Published: (2022-08-01) -
Long-term outcomes after percutaneous withdrawal of HeartWare left ventricular assist device (HVAD) support: A 10-year update
by: Chokanan Thaitirarot, et al.
Published: (2025-02-01) -
Successful heart transplantation after 4 years of bridging with HeartWare HVAD for left ventricular noncompaction in an 11-year-old boy with prohibitively high pulmonary vascular resistance
by: Komarakshi R. Balakrishnan, et al.
Published: (2024-12-01) -
Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device
by: Geetanjali Dang, et al.
Published: (2014-01-01) -
Trans-atrial Inflow Cannula Configuration for Durable HeartWare Left Ventricular Assist Device in Hypertrophic Cardiomyopathy: A Case Series and a Word of Caution
by: Darshan H. Brahmbhatt, MB BChir, MD, et al.
Published: (2025-08-01)